Forum Pharmaceuticals: Needham Healthcare Conference (Forum Pharmaceuticals) - Apr 23, 2015 - "Encenicline is Generally Well-Tolerated"; "Alzheimer's Disease; Phase 2b"; "AEs predominantly GI (mild constipation and nausea); "~2X AE frequency in add-on patients vs. de novo"; "Two GI SAEs 'possibly drug related'; SAEs more frequent overall in add-on group"
P2b data • Alzheimer's Disease
|